St. Jude is leading the way the world understands, treats and defeats childhood cancer and other life-threatening diseases.
Our Mission Statement
Facts & Figures
Visit St. Jude
For the safety of our patients, all guests must schedule their visit in advance.
262 Danny Thomas Place Memphis, TN 38105
Affiliate Clinic Locations
Does your child need treatment?
View Open Clinical Trials
Call: 1-888-226-4343 Fax: 901-595-4011 Email: email@example.com Online: Referral Form Physician / Patient Referral Office
Patient & Family Resources
My St. Jude Patient Portal
Academic Departments & Divisions
St. Jude Faculty
Comprehensive Cancer Center
Clinical & Research Innovation
Research Resources & Data
News & Publications
St. Jude Graduate School of Biomedical Sciences
Applications are now open for the 2019 entering class.
Attend a Local Event
Other ways to get involved
Volunteer at the Hospital Become a Monthly Donor
Sports and Fitness Fundraisers
Other Ways to Get Involved
Become a Monthly Donor
Why Support Us?
Other Ways to Give
St. Jude Dream Home Giveaway
Shop the St. Jude Gift Shop
For decades, the genetic basis of pediatric melanoma was a mystery. But
St. Jude scientists recently discovered the molecular signatures of three pediatric melanoma subtypes.
A spectrum of discoveries in
St. Jude labs and clinics offer promise for patients with Ewing sarcoma.
St. Jude opens the first proton therapy center designed just for children.
A new clinic brings families from across the nation to
St. Jude to increase our knowledge about this aggressive type of skin cancer.
A chemo combo pioneered at
St. Jude retains a high cure rate for retinoblastoma while preserving usable vision and lowering future cancer risk.
St. Jude Child Life unites five patients and inspires them to help one another persevere.
In the race to increase survival rates for the soft-tissue cancer rhabdomyosarcoma, one researcher surges ahead with an exciting discovery.
For childhood cancer survivor Ashley McTyre, RN, nursing is not a career, but a calling.
St. Jude harnesses technology to aid in the early detection and diagnosis of the eye cancer retinoblastoma.
A promising new therapy mobilizes a child’s immune system to help kill cancer cells.
For Patients & Families For Referring Physicians